Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice

Brain Research

Volumn 1399, Issue , 2011, Pages 33-39

  Tulloch, Ingrid ^a,b   Ghazaryan, Nane ^a   Mexhitaj, Ina ^a   Ordonez, Dalila ^a   Angulo, Jesus A ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Binge; Cytogenesis; Dopamine D1 receptor; Dopamine D2 receptor; Methamphetamine; Neurokinin 1 receptor

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; NEUROKININ 1 RECEPTOR; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; STEREOLOGY;

ANALYSIS OF VARIANCE; ANDROSTANES; ANIMALS; BENZAZEPINES; BENZIMIDAZOLES; BROMODEOXYURIDINE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG ADMINISTRATION ROUTES; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; NEUROGENESIS; RACLOPRIDE; RECEPTORS, DOPAMINE; RECEPTORS, NEUROKININ-1;

MUS;

EID: 79958810219     PISSN: 00068993     EISSN: 00068993     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.05.017     Document Type: Article

References (42)

1. Barr, A.M., Panenka, W.J., MacEwan, G.W., Thornton, A.E., Lang, D.J., Honer, W.G., Lecomte, T., 2006. The need for speed: an update on methamphetamine addiction. J. Psychiatry Neurosci. 31, 301-313. (Pubitemid 44497427)
2. Baucum II, A.J., Rau, K.S., Riddle, E.L., Hanson, G.R., Fleckenstein, A.E., 2004. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. J. Neurosci. 24, 3436-3443. (Pubitemid 38451909)
3. Bowyer, J.F., Robinson, B., Ali, S., Schmued, L.C., 2008. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse 62, 193-204. (Pubitemid 351186400)
4. Darke, S., Kaye, S., McKetin, R., Dufluo, J., 2008. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 27, 253-262.
5. Deng, X., Wang, Y., Chou, J., Cadet, J.L., 2001. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol. Brain Res. 93, 64-69.
6. Eisch, A.J., Marshall, J.F., 1998. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30, 433-445. (Pubitemid 28506998)
7. Fleckenstein, A.E., Metzger, R.R., Beyeler, M.L., Gibb, J.W., Hanson, G.R., 1997. Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334, 111-114.
8. Fornai, F., Lenzi, P., Gesi, M., Soldani, P., Ferrucci, M., Lazzeri, G., Capobianco, L., Battaglia, G., De Blasi, A., Nicoletti, M., Paparelli, A., 2004. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J. Neurochem. 88, 114-123. (Pubitemid 38030214)
9. Gross, N.B., Marshall, J.F., 2009. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience 161, 1114-1125.
10. Keefe, K.A., Gerfen, C.R., 1996. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367, 165-176.
11. Krasnova, I.N., Cadet, J.L., 2009. Methamphetamine toxicity and messengers of death. Brain Res. Rev. 60, 379-407.
12. Mark, K.A., Soghomonian, J.J., Yamamoto, B.K., 2004. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 24, 11449-11456. (Pubitemid 39658280)
13. Mao, L., Wang, J.Q., 2001. Gliogenesis in the striatumof the adult rat: alteration in neural progenitor population after psychostimulant exposure. Brain Res. Dev. Brain Res. 130, 41-51.
14. Mao, L., Lau, Y.-S., Petroske, E., Wang, J.Q., 2001. Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration. Dev. Brain Res. 131, 57-65.
15. McCann, U.D., Wong, D.F., Yokoi, F., Villemagne, V., Dannals, R.F., Ricaurte, G.A., 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11 C]WIN-35,428. J. Neurosci. 18, 8417-8422. (Pubitemid 28465016)
16. McCann, U.D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J., Ye, W., Alexander, M., Dannals, R.F., Wong, D.F., Ricaurte, G.A., 2008. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62, 91-100.
17. Melega, W.P., Raleigh, M.J., Stout, D.B., Lacan, G., Huang, S.C., Phelps, M.E., 1997. Recovery of striatal dopamine function after acute methamphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 766, 113-120. (Pubitemid 27431441)
18. Melega, W.P., Lacan, G., Desalles, A.A., Phelps, M.E., 2000. Long-term methamphetamine-induced decreases of [(11)C] WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey. Synapse 35, 243-249.
19. O'Callaghan, J.P., Miller, D.B., 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6 J mouse. J. Pharmacol. Exp. Ther. 270, 741-751.
20. Pu, C., Broening, H.W., Vorhees, C.V., 1996. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 23, 328-334. (Pubitemid 26262395)
21. Ricaurte, G.A., Schuster, C.R., Seiden, L.S., 1980. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193, 153-163. (Pubitemid 10120970)
22. Ricaurte, G.A., Guillery, R.W., Seiden, L.S., Schuster, C.R., Moore, R.Y., 1982. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93-103. (Pubitemid 12188130)
23. Schmidt, C.J., Ritter, J.K., Sonsalla, P.K., Hanson, G.R., Gibb, J.W., 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
24. Scott, J.C., Woods, S.P., Matt, G.E., Meyer, R.A., Heaton, R.K., Atkinson, J.H., Grant, I., 2007. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17, 275-297.
25. Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., Tsuchiya, K.J., Tsukada, H., Iyo, M., Mori, N., 2006. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch. Gen. Psychiatry 63, 90-100.
26. Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K.J., Suda, S., Suzuki, K., Kawai, M., Takebayashi, K., Yamamoto, S., Matsuzaki, H., Ueki, T., Mori, N., Gold, M.S., Cadet, J.L., 2008. Methamphetamine causes microglial activation in the brain of human abusers. J. Neurosci. 28, 5756-5761.
27. Sonsalla, P.K., Gibb, J.W., Hanson, G.R., 1986. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J. Pharmacol. Exp. Ther. 238, 932-937.
28. Thomas, D.M., Walker, P.D., Benjamins, J.A., Geddes, T.J., Kuhn, D.M., 2004. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 311, 1-7.
29. Thomas, D.M., Francescutti-Verbeem, D.M., Kuhn, D.M., 2008. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling. J. Neurochem. 105, 605-616.
30. Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong, M.S., Sui, Y., Lee, J.Y., Toga, A.W., Ling, W., London, E.D., 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24, 6028-6036.
31. United Nations Office on Drugs and Crime, 2007. World Drug Report. Analysis, Vol. 1. United Nations Office on Drugs and Crime, Vienna.
32. Villemagne, V., Yuan, J., Wong, D.F., Dannals, R.F., Hatzidimitriou, G., Mathews, W.B., Ravert, H.T., Musachio, J., McCann, U.D., Ricaurte, G.A., 1998. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11 C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J. Neurosci. 18, 419-427. (Pubitemid 28046799)
33. Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi, D., Sedler, M., Gatley, S.J., Miller, E., Hitzemann, R., Ding, Y.S., Logan, J., 2001. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21, 9414-9418. (Pubitemid 33096884)
34. Wang, J., Angulo, J.A., 2011a. Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice. Synapse 65, 300-308.
35. Wang, J., Angulo, J.A., 2011b. Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice. Brain Res. 1369, 131-139.
36. Xu, W., Zhu, J.P.Q., Angulo, J.A., 2005. Induction of striatal pre- and post-synaptic damage by methamphetamine requires the dopamine receptors. Synapse 58, 110-121. (Pubitemid 41443747)
37. Yu, J., Cadet, J.L., Angulo, J.A., 2002. Neurokinin-1 (NK-1) receptor antagonists abrogate the methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J. Neurochem. 83, 613-622. (Pubitemid 35231815)
38. Yu, J., Wang, J., Cadet, J.L., Angulo, J.A., 2004. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine- induced neurotoxicity in the mouse brain. Brain Res. 1007, 124-131. (Pubitemid 38520180)
39. Zhu, J.P.Q., Xu, W., Angulo, J.A., 2005. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res. 1049, 171-181. (Pubitemid 41072933)
40. Zhu, J.P.Q., Xu, W., Angulo, J.A., 2006a. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 140, 607-622.
41. Zhu, J.P.Q., Xu, W., Angulo, N., Angulo, J.A., 2006b. Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration. Neurotoxicology 27, 131-136. (Pubitemid 41745016)
42. Zhu, J., Xu, W., Wang, J., Ali, S.F., Angulo, J.A., 2009. The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. J. Neurochem. 111, 656-668.